Daiichi Sankyo Company (4568-TO)

QUOTE AND NEWS
The Hindu Business Line  Apr 11  Comment 
Shadow of Daiichi Sankyo taking Singh brothers to court still looms
The Economic Times  Apr 4  Comment 
The Singh brothers and promoter groups currently hold less than 1% in Fortis Healthcare compared with 34.43% in December 2017 because most of their holdings were pledged to banks.
FiercePharma  Apr 1  Comment 
A new disease awareness campaign from Daiichi Sankyo highlights iron deficits common in patients with Crohn’s disease and ulcerative colitis. Daiichi is working with the Crohn’s & Colitis Foundation on the campaign, called “Get Iron...
The Hindu Business Line  Apr 1  Comment 
Japanese pharma major says move will violate court rulings in its favour
GenEng News  Mar 1  Comment 
Daiichi Sankyo is eliminating approximately 280 U.S. jobs in a restructuring it said will better align its U.S. commercial operations with its current portfolio of marketed drugs and pipeline of cancer treatments. The 280 to be laid off are...
The Economic Times  Feb 12  Comment 
The Singhs and a company controlled by them have sought the apex court’s permission to appeal the judgement, said people familiar with the development.
The Hindu Business Line  Jan 31  Comment 
Stock spikes 11% after judgment favouring Daiichi Sankyo in dispute with Ranbaxy
MedPage Today  Jan 30  Comment 
(MedPage Today) -- Enteropathy identified more commonly than with other ARBs
The Economic Times  Jan 30  Comment 
Daiichi and the Singhs have been locked in litigation since 2016 over whether the firm can enforce its award in India.





You may also be interested in articles related to Daiichi Sankyo Company (4568-TO):
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki